THE UTILITY OF A CARCINOGEN-INDUCED RAT MAMMARY CANCER AS A CHEMOTHERAPEUTIC SCREENING DEVICE.
D000818:Animals; D001943:Breast Neoplasms; D002273:Carcinogens; D003520:Cyclophosphamide; D003609:Dactinomycin; D004032:Diet; D004035:Diet Therapy; D006801:Humans; D015674:Mammary Neoplasms, Animal; D008325:Mammary Neoplasms, Experimental; D008466:Mechlorethamine; D015122:Mercaptopurine; D008727:Methotrexate; D008748:Methylcholanthrene; D009369:Neoplasms / Q000628:therapy*; D051381:Rats; D012106:Research; D014116:Toxicology
D002273:Carcinogens; D003609:Dactinomycin; D008466:Mechlorethamine; D008748:Methylcholanthrene; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate
ACTINOMYCIN; CYCLOPHOSPHAMIDE; DIET THERAPY; EXPERIMENTAL LAB STUDY; MAMMARY NEOPLASMS, EXPERIMENTAL; MECHLORETHAMINE; MERCAPTOPURINE; METHOTREXATE; METHYLCHOLANTHRENE; NEOPLASM THERAPY; RATS; TOXICOLOGIC REPORT